Allergy Therapeutics
AGY.L
#7195
Rank
NZ$0.73 B
Marketcap
$0.15
Share price
7.69%
Change (1 day)
215.24%
Change (1 year)

EPS for Allergy Therapeutics (AGY.L)

EPS in 2023: -$0.17

According to Allergy Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.17. In 2023 the company made an earnings per share (EPS) of -$0.17 a decrease over its 2022 EPS that were of -$0.04605.

EPS history for Allergy Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023-$0.17269.76%
2022-$0.04605-516.78%
2021$0.01105-54.41%
2020$0.0242495.71%
2019$0.01238-141.62%
2018-$0.02975206.98%
2017-$0.009693-82.28%
2016-$0.05470-9900.7%
2015$0.0005581-88.46%
2014$0.00483437.81%
2013$0.003508-49.58%
2012$0.006957-128.37%
2011-$0.02452-562.56%
2010$0.005301-101.26%
2009-$0.42-52.19%
2008-$0.88-13.07%
2007-$1.01230.64%
2006-$0.31182.5%
2005-$0.11-211.47%
2004$0.09685-59.61%
2003$0.24-219.2%
2002-$0.20